Grail is raising at least $1 billion to fund its early cancer screening test

 The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing today, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only mentioning in a release the funding will come “primarily from undisclosed private and strategic investors,” Microsoft co-founder Bill Gates, Amazon founder Jeff Bezos, Google… Read More
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.